Skip to content
  • Saturday, May 17, 2025

VRT Pharma

Regulatory and Clinical Strategy Consulting

  • Home
  • About Us
  • Fields and Areas of Specialization
    • Regulatory Strategy
    • Quality Assurance Consulting
    • Project Management
  • Media
    • Press Releases
  • Career
  • Contact Us
Top Stories
Healthcare sector advocates for innovation, infrastructure boost, and NCD Focus in Budget 2024-25Zydus gets USFDA nod for Gabapentin tablets (once-daily), 300 mg and 600 mgUS FDA approves Dupixent to treat younger kids with esophageal condition
Healthcare sector advocates for innovation, infrastructure boost, and NCD Focus in Budget 2024-25Zydus gets USFDA nod for Gabapentin tablets (once-daily), 300 mg and 600 mgUS FDA approves Dupixent to treat younger kids with esophageal condition

Main Stories

Press Release

Zydus gets USFDA nod for Gabapentin tablets (once-daily), 300 mg and 600 mg

January 26, 2024
sarat puli
Press Release

US FDA approves Dupixent to treat younger kids with esophageal condition

January 26, 2024
sarat puli
Press Release

Healthcare sector advocates for innovation, infrastructure boost, and NCD Focus in Budget 2024-25

January 26, 2024
sarat puli
Press Release

Zydus gets USFDA nod for Gabapentin tablets (once-daily), 300 mg and 600 mg

January 26, 2024
sarat puli
Press Release

US FDA approves Dupixent to treat younger kids with esophageal condition

January 26, 2024
sarat puli
Press Release

Healthcare sector advocates for innovation, infrastructure boost, and NCD Focus in Budget 2024-25

January 26, 2024
sarat puli
Press Release

Zydus gets USFDA nod for Gabapentin tablets (once-daily), 300 mg and 600 mg

January 26, 2024
sarat puli

Editor's Pick

Press Release

Healthcare sector advocates for innovation, infrastructure boost, and NCD Focus in Budget 2024-25

January 26, 2024
sarat puli
Press Release

Zydus gets USFDA nod for Gabapentin tablets (once-daily), 300 mg and 600 mg

January 26, 2024
sarat puli

Trending Stories

Press Release

Healthcare sector advocates for innovation, infrastructure boost, and NCD Focus in Budget 2024-25

January 26, 2024
sarat puli
Press Release

Zydus gets USFDA nod for Gabapentin tablets (once-daily), 300 mg and 600 mg

January 26, 2024
sarat puli

Popular Stories

Press Release

Healthcare sector advocates for innovation, infrastructure boost, and NCD Focus in Budget 2024-25

January 26, 2024
sarat puli
Press Release

Zydus gets USFDA nod for Gabapentin tablets (once-daily), 300 mg and 600 mg

January 26, 2024
sarat puli
Press Release

US FDA approves Dupixent to treat younger kids with esophageal condition

January 26, 2024
sarat puli

You may Missed

Press Release

Healthcare sector advocates for innovation, infrastructure boost, and NCD Focus in Budget 2024-25

January 26, 2024
sarat puli
Press Release

Zydus gets USFDA nod for Gabapentin tablets (once-daily), 300 mg and 600 mg

January 26, 2024
sarat puli
Press Release

US FDA approves Dupixent to treat younger kids with esophageal condition

January 26, 2024
sarat puli
Copyright © 2025 VRT Pharma
Theme by: Theme Horse
Proudly Powered by: WordPress